{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:16:32Z","timestamp":1775276192500,"version":"3.50.1"},"reference-count":41,"publisher":"Baishideng Publishing Group Inc.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Diabetes"],"abstract":"<jats:p>BACKGROUND<\/jats:p>\n          <jats:p>Adult-onset diabetes is most often considered to be type 2 diabetes. However, other types of diabetes can develop in adults, including exocrine pancreas disease-associated diabetes, also called type 3c diabetes. Differential diagnosis between these types of diabetes still remains a diagnostic challenge.<\/jats:p>\n          <jats:p>AIM<\/jats:p>\n          <jats:p>To define anthropometric and laboratory markers that will allow for early diagnosis of pancreatic disease-associated diabetes.<\/jats:p>\n          <jats:p>METHODS<\/jats:p>\n          <jats:p>The study group included 44 patients with pancreatogenic diabetes (26 with pancreatic cancer and 18 with chronic pancreatitis), while the control group consisted of 35 patients with type 2 diabetes. We analyzed several parameters, including sex, age, body mass index (BMI), fasting plasma glucose, fasting C-peptide and insulin with homeostasis model assessment of insulin resistance (HOMA-IR) index calculation, adrenomedullin, adiponectin and creatinine levels with epidermal growth factor receptor (eGFR) calculation. We also developed an equation, termed type 3c diabetes index, which utilized BMI, fasting insulin and adrenomedullin levels, and eGFR to better identify patients with type 3c diabetes.<\/jats:p>\n          <jats:p>RESULTS<\/jats:p>\n          <jats:p>Compared to patients with type 2 diabetes, patients with pancreatogenic diabetes had significantly lower BMI (25.11 \u00b1 4.87 kg\/m2 vs  30.83 \u00b1 5.21 kg\/m2), fasting C-peptide (0.81 \u00b1 0.42 nmol\/L vs  1.71 \u00b1 0.80 nmol\/L), insulin (76.81 \u00b1 63.34 pmol\/L vs  233.19 \u00b1 164.51 pmol\/L) and HOMA-IR index, despite similar fasting plasma glucose levels. Patients with pancreatogenic diabetes also had lower adrenomedullin levels (0.41 \u00b1 0.25 ng\/mL vs  0.63 \u00b1 0.38 ng\/mL) but higher adiponectin levels (13.08 \u00b1 7.20 \u03bcg\/mL vs  8.28 \u00b1 4.01 \u03bcg\/mL) and eGFR levels (100.53 \u00b1 21.60 mL\/min\/1.73 m2 vs  85.14 \u00b1 19.24 mL\/min\/1.73 m2). Finally, patients with pancreatogenic diabetes had significantly lower Type 3c diabetes index values.<\/jats:p>\n          <jats:p>CONCLUSION<\/jats:p>\n          <jats:p>Patients with pancreatogenic diabetes differ from patients with type 2 diabetes in anthropometric and laboratory parameters. The type 3c diabetes index had the highest discriminating value, above any single parameter.<\/jats:p>","DOI":"10.4239\/wjd.v16.i2.95102","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T02:12:23Z","timestamp":1735524743000},"source":"Crossref","is-referenced-by-count":2,"title":["Distinguishing exocrine pancreas disease-associated diabetes from type 2 diabetes based on anthropometric and metabolic parameters"],"prefix":"10.4239","volume":"16","author":[{"given":"Anna","family":"Juza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilianna","family":"Ko\u0142odziej-Spirodek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Gutkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariusz","family":"Partyka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariusz","family":"D\u0105browski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","published-online":{"date-parts":[[2025,2,15]]},"reference":[{"key":"B1","unstructured":"World Health Organization.   Classification of diabetes mellitus. Aug 6, 2021. [cited 18 August 2024]. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/325182\/9789241515702-eng.pdf"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.5114\/ctd\/183052"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-S002"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31318-0"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(16)30106-6"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.49"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-12-0105"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2012.12.025"},{"key":"B9","unstructured":"Zhang Y, Yang J, Li H, Wu Y, Zhang H, Chen W. Tumor markers CA19-9, CA242 and CEA in the diagnosis of pancreatic cancer: a meta-analysis. Int J Clin Exp Med 2015; 8: 11683-11691"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14081866"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29485"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/biom12020156"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.589218"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.926230"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218308"},{"key":"B16","unstructured":"Didkowska J, Wojciechowska U, Olasek P, dos Santos FC, Micha\u0142ek I.   Nowotwory z\u0142o\u015bliwe w Polsce w 2019 roku, Cancer in Poland in 2019. [cited 18 August 2024]. Available from: https:\/\/onkologia.org.pl\/sites\/default\/files\/publications\/2022-05\/Nowotwory_2019.pdf"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.5603\/njo.2017.0057"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21654"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30416-9"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14204991"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1159\/000493473"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-020-00324-z"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2019190011"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1385068"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4321\/s1130-01082012000600006"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0000000000000754"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i30.4939"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2020.05.010"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.19411"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2015.12.003"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2015.2345"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.08.044"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.15761\/icst.1000175"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-3362"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007502"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.5301\/tj.5000693"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c170046"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjw011"},{"key":"B39","unstructured":"Dranka-Bojarowska D, Lekstan A, Olakowski M, Jablonska B, Lewinski A, Musialski P, Sobczyk W, Kapalka A, Lampe P. The assessment of serum concentration of adiponectin, leptin and serum carbohydrate antigen-19.9 in patients with pancreatic cancer and chronic pancreatitis. J Physiol Pharmacol 2015; 66: 653-663"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-015-3972-6"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djs474"}],"container-title":["World Journal of Diabetes"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/1948-9358\/full\/v16\/i2\/95102.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/1948-9358\/full\/v16\/i2\/95102.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T02:12:38Z","timestamp":1735524758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/1948-9358\/full\/v16\/i2\/95102.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,15]]},"references-count":41,"journal-issue":{"issue":"2"},"alternative-id":["95102"],"URL":"https:\/\/doi.org\/10.4239\/wjd.v16.i2.95102","relation":{},"ISSN":["1948-9358"],"issn-type":[{"value":"1948-9358","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,15]]}}}